Insife Annual Convention 2024
Connect. Collaborate. Community.
Speakers
Global Head PS&PV External Engagements, Novartis
Thomas McConnon
Martin Holm-Petersen
CEO, Insife
We had a remarkable day filled with inspiring discussions and valuable insights into pharmacovigilance.
Attendees engaged with distinguished speakers, including Thomas McConnon, Global Head PS&PV External Engagements, Novartis, who presented on "ReVA – Supporting Portfolio Transformation via Digitalisation of End-to-End PV Agreements Management," and Thomas Hornbæk Svendsen, Consulting Director, R&D Solutions, NNIT and Helle von der Recke-Heisel Vice President of Global Drug Safety and QPPV at Pharmacosmos, who provided an in-depth look at the project lifecycle from preparation to hypercare through a real-world example.
It was a fantastic opportunity to connect, collaborate, and build a sense of community among professionals dedicated to advancing the field of pharmacovigilance. We hope you left feeling inspired and equipped with new knowledge to implement in your work.
Missed a Session? Request Access to the Recording!
If you would like to access the recordings of the sessions, please fill out the form below. We want to ensure you don’t miss out on any valuable insights!
James Whitehead
Senior Director at AstraZeneca
Chris McCurdy
Chief Architect, Healthcare and Life Sciences AWS
Michael von Forstner
Head of Global Safety Science, SOBI
Sarah Vaughan
Head of Vigilance Operations at MHRA
Phil Tregunno
Deputy Director, Patient Safety Monitoring, Safety and Surveillance, MHRA
Helle von der Recke-Heisel
Vice President of Global Drug Safety
and QPPV, Pharmacosmos
Thomas Hornbæk Svendsen
Consulting Director, R&D Solutions, NNIT
Florian Goergens
Project Lead, Bayer
Henry Barton
Global Safety Lead, Grünenthal
Louise Tan
Head of GRIP Services, Insife
